Guardant Health International — Revenue decreased by 3.9% to $17.04M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 72.7%, from $9.86M to $17.04M. Over 4 years (FY 2021 to FY 2025), International — Revenue shows an upward trend with a 29.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates successful international market penetration and growing global demand for the company's diagnostic products, while a decrease may signal competitive pressures, regulatory hurdles, or challenges in local distribution.
This metric represents the total gross revenue generated from sales and services provided to customers located outside o...
Peers in the life sciences and diagnostics sector typically report international revenue as a percentage of total revenue to demonstrate global diversification and the scalability of their commercial infrastructure.
gh_segment_international_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.23M | $4.36M | $6.14M | $5.23M | $8.31M | $6.31M | $9.08M | $9.80M | $7.89M | $7.30M | $12.44M | $11.14M | $9.12M | $11.37M | $10.22M | $9.86M | $15.40M | $15.76M | $17.72M | $17.04M |
| QoQ Change | — | +3.0% | +40.8% | -14.8% | +58.9% | -24.1% | +43.9% | +8.0% | -19.5% | -7.5% | +70.5% | -10.4% | -18.2% | +24.7% | -10.1% | -3.5% | +56.2% | +2.3% | +12.5% | -3.9% |
| YoY Change | — | — | — | — | +96.3% | +44.7% | +47.9% | +87.5% | -5.1% | +15.6% | +37.0% | +13.7% | +15.6% | +55.9% | -17.8% | -11.5% | +68.9% | +38.6% | +73.4% | +72.7% |